Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection.
Douglas
R M
RM
Albrecht
J K
JK
Miles
H B
HB
Moore
B W
BW
Read
R
R
Worswick
D A
DA
Woodward
A J
AJ
D000260:Adenoviruses, Human / Q000302:isolation & purification; D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000368:Aged; D003139:Common Cold / Q000517:prevention & control / Q000635:transmission; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009666:Nose / Q000382:microbiology; D011897:Random Allocation; D012141:Respiratory Tract Infections / Q000517:prevention & control* / Q000635:transmission; D018108:Respirovirus / Q000302:isolation & purification; D012229:Rhinovirus / Q000302:isolation & purification; D014777:Virus Diseases / Q000517:prevention & control*
D007370:Interferon Type I